Skip to main content Skip to main navigation menu Skip to site footer
MedNext Journal of Medical and Health Sciences
Highlight
DOI: 10.54448/mdnt21610
Submitted: 15-12-2021
Published: 15-12-2021

Relationship between Kawasaki disease and COVID-19 for the development of MIS-C in children: a brief systematic review

FACERES – Medical School of São José do Rio Preto, São Paulo, Brazil
UNIDA – Medical School of Ciudad Del Este, Paraguay
FACERES – Medical School of São José do Rio Preto, São Paulo, Brazil
Kawasaki disease MIS-C COVID-19

Metrics

Metrics Loading ...

References

  1. Silva CA, Queiroz LB, Fonseca CB, Silva LE, Lourenço B, Marques HH. Spotlight for healthy and preexisting chronic diseases adolescents during COVID-19 pandemic.
  2. Palmeira P, Barbuto JAM, Silva CAA, Carneiro-Sampaio M. Why is SARS-CoV-2 infection milder among children? Clinics (Sao Paulo). 2020;75:e1947.
  3. Mahase E. Covid-19: concerns grow over inflammatory syndrome emerging in children. BMJ. 2020;369:m1710.
  4. Riphagen S, Gomez X, Gonzalez-Martinez C, Wilkinson N, Theocharis P. Hyperinflammatory shock in children during COVID-19 pandemic. Lancet. 2020;395(10237):1607–8.
  5. Panupattanapong S, Brooks EB. New spectrum of COVID-19 manifestations in children: Kawasaki-like syndrome and hyperinflammatory response. Cleve Clin J Med [Internet]. 2020; Disponível em: http://dx.doi.org/10.3949/ccjm.87a.ccc039
  6. McCrindle BW, Rowley AH, Newburger JW, Burns JC, Bolger AF, Gewitz M, et al. Diagnosis, treatment, and long-term management of Kawasaki disease: A scientific statement for health professionals from the American Heart Association. Circulation. 2017;135(17):e927–99.
  7. Sundel R, Klein-Gitelman M, Kaplan SL, TePas E. Kawasaki disease: complications.
  8. Alongi A, Naddei R, De Miglio L, Natoli V, Ravelli A. Macrophage activation syndrome in pediatrics. Pediatr Allergy Immunol. 2020;31 Suppl 24:13–5.
  9. Crayne C, Cron RQ. Pediatric macrophage activation syndrome, recognizing the tip of the Iceberg. Eur J Rheumatol. 2019;7(1):1–8.
  10. Natoli V, Rosina S, Ravelli A. Is macrophage activation syndrome in Kawasaki disease underrecognized? J Rheumatol. 2021;48(2):162–4.
  11. Paediatric multisystem inflammatory syndrome temporally associated with COVID-19 (PIMS) - guidance for clinicians [Internet]. Rcpch.ac.uk. [citado 9 de setembro de 2021]. Disponível em: https://www.rcpch.ac.uk/resources/guidance-paediatric-multisystem-inflammatory-syndrome-temporally-associated-covid-19-pims
  12. HAN Archive - 00432 [Internet]. Cdc.gov. 2020 [citado 9 de setembro de 2021]. Disponível em: https://emergency.cdc.gov/han/2020/han00432.asp
  13. (hq) WH. Multisystem inflammatory syndrome in children and adolescents with COVID-19 [Internet]. Who.int. World Health Organization; 2020 [citado 9 de setembro de 2021]. Disponível em: https://www.who.int/publications/i/item/multisystem-inflammatory-syndrome-in-children-and-adolescents-with-covid-19.
  14. Verdoni L, Mazza A, Gervasoni A, Martelli L, Ruggeri M, Ciuffreda M, et al. An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study. Lancet. 2020;395(10239):1771–8.
  15. Son MBF. Pediatric inflammatory syndrome temporally related to covid-19. BMJ. 2020;369:m2123.
  16. Toubiana J, Poirault C, Corsia A, Bajolle F, Fourgeaud J, Angoulvant F, et al. Kawasaki-like multisystem inflammatory syndrome in children during the covid-19 pandemic in Paris, France: prospective observational study. BMJ. 2020;369:m2094.
  17. Grimaud M, Starck J, Levy M, Marais C, Chareyre J, Khraiche D, et al. Acute myocarditis and multisystem inflammatory emerging disease following SARS-CoV-2 infection in critically ill children. Ann Intensive Care. 2020;10(1):69.
  18. Whittaker E, Bamford A, Kenny J, Kaforou M, Jones CE, Shah P, et al. Clinical characteristics of 58 children with a pediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2. JAMA. 2020;324(3):259–69.
  19. MG, FM, Em B. Miocardite em um menino de 16 anos positivo para SARS-CoV-2. Lanceta. 2020;395 116.
  20. RC S, H MS, D M, J S, L D. Miocardite eosinofílica fatal em um homem de 17 anos saudável com síndrome respiratória aguda grave coronavírus 2 (SARS-CoV-2c. Fetal Pediatr Pathol. 2020;39:263–268.
  21. Chiotos K, Bassiri H, Behrens EM, Blatz AM, Chang J, Diorio C, et al. Multisystem inflammatory syndrome in children during the Coronavirus 2019 pandemic: A case series. J Pediatric Infect Dis Soc. 2020;9(3):393–8.
  22. Rivera-Figueroa EI, Santos R, Simpson S, Garg P. Incomplete Kawasaki disease in a child with covid-19. Indian Pediatr. 2020;57(7):680–1.
  23. Rauf A, Vijayan A, John ST, Krishnan R, Latheef A. Multisystem inflammatory syndrome with features of atypical Kawasaki disease during COVID-19 pandemic. Indian J Pediatr. 2020;87(9):745–7.
  24. Jones VG, Mills M, Suarez D, Hogan CA, Yeh D, Segal JB, et al. COVID-19 and Kawasaki disease: Novel virus and novel case. Hosp Pediatr. 2020;10(6):537–40.
  25. Yuki K, Fujiogi M, Koutsogiannaki S. COVID-19 pathophysiology: A review. Clin Immunol. 2020;215(108427):108427.
  26. Xu S, Chen M, Weng J. COVID-19 and Kawasaki disease in children. Pharmacol Res. 2020;159(104951):104951.
  27. Santos BS dos, Santos FS dos, Ribeiro ER. Clinical-epidemiological relation between SARS-CoV-2 and Kawasaki disease: An integrative literature. Rev Paul Pediatr [Internet]. 2021;39. Disponível em: http://dx.doi.org/10.1590/1984-0462/2021/39/2020217
  28. Silveira J de O, Pegoraro MG, Ferranti JF, Bousso A, Renattini TSM. Influenza B infection and Kawasaki disease in an adolescent during the COVID-19 pandemic: a case report. Rev Bras Ter Intensiva. 2021;33(2):320–4.
  29. Paediatric inflammatory multisystem syndrome, V- S-C. RAPID RISK ASSESSMENT [Internet]. Europa.eu. [citado 9 de setembro de 2021]. Disponível em: https://www.ecdc.europa.eu/sites/default/files/documents/covid-19-risk-assessment-paediatric-inflammatory-multisystem-syndrome-15-May-2020.pdf

How to Cite

Pitoscia, G. O., Valverde Salvia Junior, L. C., & Faria, T. V. (2021). Relationship between Kawasaki disease and COVID-19 for the development of MIS-C in children: a brief systematic review. MedNEXT Journal of Medical and Health Sciences, 2(6). https://doi.org/10.54448/mdnt21610